Search

everythinglearnresearchcommunity

for

Search:↓

miR-199a-3p controls hair growth and is linked to alopecia areata.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Patients with non-scarring alopecia often experience emotional disorders like depression and stress.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

Betamethasone dipropionate lotion is more effective than minoxidil solution for treating Alopecia Areata.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Americans see hair transplants as valuable for treating hair loss and want them to be more affordable and tailored to each gender.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

People with alopecia often feel anxious, depressed, and have low self-esteem.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

The conclusions are: fecal short-chain fatty acids may help prevent cancer, fiber intake can reduce obesity, weight loss is hard for obese people, low BMI cancer patients are more prone to chemotherapy side effects, intermittent fasting benefits gut health, cherry laurel has health benefits in rats, certain gene variations can increase stress in hair loss patients, fecal acids can affect blood sugar levels, cold agglutinin can affect blood test results in autoimmune patients, and people with Crohn's disease have higher levels of a certain chemical in their blood.

A holistic treatment approach, including yoga, diet, exercise, and mindfulness, can effectively manage PCOS symptoms.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Nourkrin® Woman with Marilex® improves hair growth, appearance, and confidence in women with hair loss.

Patients with non-scarring hair loss often have emotional disorders.

Large data can lead to new medical discoveries and personalized medicine.

American men are older, more obese, and have longer infertility than Canadian men.

The growth factor cocktail significantly increased hair growth in patients with androgenetic alopecia.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.